Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib-Combined Chemotherapy for Newly Diagnosed Ph+ ALL
NCT00130195Phase 2Completed
- Sponsor
- Japan Adult Leukemia Study Group
- Start
- Sep 2002
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Japan Adult Leukemia Study Group. Started Sep 2002; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00130195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130195.